The FINANCIAL — Bausch + Lomb, the global eye health company, has appointed Rodney (Rod) W. Unsworth as president, Asia-Pacific, effective July 1.
“Rod has an extensive and successful record of driving transformational change in global health care companies, with a particular focus on Asia-Pacific,” said Brent Saunders, chief executive officer, Bausch + Lomb. “His counsel and leadership will be extremely valuable as we work to build B+L into a high-performance competitor in Asia and worldwide.”
“There are exciting opportunities for B+L in this dynamic growth region,” said Mr. Unsworth. “I look forward to working with our teams across Asia-Pacific to build high performance for our company, for our customers, and for patients.”
Mr. Unsworth served as president, Asia-Pacific, for Schering-Plough Corporation from 2004 until its merger with Merck in 2009. In that role, he led a performance turnaround in key markets such as China.
From 1995 to 2002, he led transformational change with Pharmacia as president, Asia-Pacific; global vice president, Ophthalmology and Metabolic Diseases; and managing director, Pharmacia & Upjohn Australia.
In 1972, Mr. Unsworth founded Delta West, the Australian pharmaceuticals company, and served as its chairman and managing director for two decades. The company was acquired by Upjohn in 1992.
Mr. Unsworth earned his degree in pharmacy from the Victorian College of Pharmacy (Australia).
Mr. Unsworth succeeds David Edwards, who has resigned to pursue other activities. Mr. Edwards will continue to advise the company during a transition period. “We thank David for his contributions to the company and for establishing a strong foundation for future success,” said Mr. Saunders.